CTXR
Citius Pharmaceuticals, Inc.
Key Financials
Revenue
$0
NaN%
Gross Profit
$3.2M
N/A
Operating Income
$-38525608
↑ 8.3%
Net Income
$-32542912
↑ 3.3%
EPS (Diluted)
$-3.38
↑ 43.4%
Total Liabilities
$53.4M
↑ 25.5%
Shareholders' Equity
$67.6M
↓ 3.6%
Total Assets
$130.9M
↑ 12.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CTXR |
| Company Name | Citius Pharmaceuticals, Inc. |
| CIK | 1506251 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0930 |
| State of Incorporation | NV |
| Phone | (908) 967-6676 |